When administered by intratumoral injection in B16-F10 melanoma and 4T1 breast tumor models in mice, it suppressed tumor growth and increased the activation of M1 macrophages, dendritic cells, and CD4+/CD8+ T cells. Here, CD8A is linked to breast neoplasm.